Better connections. Smarter healthcare.
Every medical breakthrough starts with understanding real patients. We create the vital connections that make these discoveries possible—ethically, efficiently, and with impact.
Better connections. Smarter healthcare.
Every medical breakthrough starts with understanding real patients. We create the vital connections that make these discoveries possible—ethically, efficiently, and with impact.
Where we were.
From napkin-to-Nasdaq and beyond.
What began as a simple question “Why is it so hard to connect researchers with the right patients?” led our founders on an extraordinary journey. We transformed that question into a public company, building the first major marketplace for biospecimens. But we also discovered something crucial along the way: the traditional model of working through healthcare providers created unnecessary barriers between researchers and patients.
The next venture.
Now, with Joined Bio, we’re breaking down those barriers and creating something revolutionary: a direct-to-patient marketplace that puts individuals in control of their healthcare journey. It starts with helping researchers get biospecimens but extends far beyond – enabling individuals to manage access to their data, participate in clinical research, and engage with healthcare-related opportunities that matter to them.
Where we’re going.
Empowering patient choice.
This isn’t just another healthcare data platform – it’s a fundamental shift in how patients participate in advancing medicine. By removing institutional barriers and creating direct connections, Joined Bio is giving individuals the power to decide how their health information and biological samples contribute to scientific progress.
Where innovation meets impact.
Our marketplace platform brings cutting-edge technology to life with an elegantly simple interface. Advanced AI matching algorithms connect the right individuals and their health data with the right opportunities – whether for biospecimens, clinical studies, or data . Built with privacy protection at its core, we’ve created a secure ecosystem where participants control their own data and researchers find exactly what they need.
Why we’re different.
Putting participants first
We believe everyone should have a voice in how their healthcare data and biospecimens contribute to medical research. That’s why we’ve built trust and transparency into every aspect of our platform – giving individuals control of when and how to participate.
Experience meets innovation
Our team brings decades of experience in healthcare, marketplaces, technology, and life sciences. But we’re not just industry veterans – we’re innovators who understand that yesterday’s solutions won’t solve tomorrow’s challenges.
Valuing every connection
Every sample, every data point, every connection we facilitate has the potential to advance medicine. We make these connections with purpose, precision, and an unwavering commitment to privacy and compliance.
Leadership team
Christopher Ianelli
Founder & Co-CEO
Chris is co-CEO of Joined Bio, where he’s helping to build the future of patient access. Previously, he founded iSpecimen, transforming how researchers access biospecimens and driving innovation in precision medicine. As a former Managing Director at Leerink Partners, he launched several successful healthcare ventures, including Humedica, which was acquired by UnitedHealth Group.
He holds an MD/PhD in Immunology from Tufts and completed his residency as Chief Resident at Brigham & Women’s Hospital and Harvard Medical School. Despite his impressive credentials, he’d rather talk about old crooner music and cooking, including how to make 20 quiches at once in a home kitchen.
Jill Mullan
Founder & Co-CEO
Jill is co-CEO of Joined Bio, bringing her engineering mindset and business acumen to revolutionize patient marketplaces. Previously, as co-founder and COO of iSpecimen, she orchestrated everything from supply partnerships to biospecimen operations to marketing to corporate strategy, while keeping a watchful eye on privacy and security (no small feat in healthcare!).
Her 25+ year journey also includes launching groundbreaking products at Avid Technology, where she has responsibility for a cool $400M product line, and running product marketing and communications as a founding team member of Storigen Systems. She holds a BS in Electrical Engineering from Cornell and an MBA from Stanford. Outside of work, she’s most passionate about health and baking, and can make all sorts of whole grain foods that actually taste good.
Bill O’Donnell
Chief Technology Officer
Bill O’Donnell is Joined Bio’s CTO, but he is a also a multi-talented individual with a passion for music, particularly guitar playing and piano.
Aside from his musical talents, Bill has held key technical leadership roles in esteemed organizations like KAYAK, Lola, Blade LLC, Intuit, Inc., Boston Light Software, Digital Direct Network, NetCentric USA, Interleaf, Inc., Marposs Techno, and Digital Equipment Corp.
He is a dedicated athlete who has completed 46 half marathons since 2013 and achieved impressive personal records in various race categories.
Educationally, Bill holds a BS in Computer Engineering from Carnegie Mellon University.
Bill Arteca
Head of Growth & Operations
Bill Arteca is the Head of Growth and Operations at Joined Bio. With a deep understanding of both scientific research and commercialization, he has a proven track record of scaling biotech companies by bridging the gap between lab-driven innovation and market success.
Prior to Joined Bio, he spearheaded the commercial expansion of industry leaders such as Ohaus, Sanguine, & Avrok Bio. His leadership accelerated revenue and market impact, including Avrok Bio’s ascent from startup to over $100,000 in monthly revenue and Sanguine’s valuation soaring. In 2024, Bill founded BioSample Connect, a platform for human biospecimen procurement (now part of Joined Bio). Within just six months, BioSample Connect achieved over $500,000 in bookings, positioning the company as a rising force in the industry.
Bill holds an M.S. in Biotechnology from Kean University. He is an avid history buff, having seen more WWII documentaries than he wants to admit.
Erik Uribe
Head of Commercialization
Erik is Joined Bio’s Head of Commercialization, bringing his expertise in biospecimen sales leadership and strategic revenue growth to drive Joined Bio’s researcher acquisition. He has a proven track record of transforming sales organizations and driving exceptional results in the life sciences industry.
Most recently, as Client Director at Audubon Bioscience, Erik restructured the entire revenue team and launched a successful outbound prospecting program that delivered over 100% revenue growth. His experience spans leadership roles at iSpecimen and Discovery Life Sciences, where he built and managed high-performing biospecimen sales teams, seamlessly onboarded supplier networks, and spearheaded complex global IT implementations.
Erik holds an MBA from The University of Alabama in Huntsville and graduated summa cum laude with a BA from The University of Alabama. When he’s not closing deals or strategizing market expansion, you’ll find him experimenting with new recipes in the kitchen or “hamming it up” on amateur radio.